Ebru ÖRSAL, Bedri SEVEN, Mustafa Teoman ERDEM, Erhan VAROĞLU, Hatice FARIMAZ, Arif Kürşad AYAN

Evaluation of the effect of isotretinoin on salivary gland function by Tc-99m pertechnetate imaging in acne vulgaris patients

Background/aim: Isotretinoin is an effective drug utilized in the management of acne vulgaris and is known to cause dry mouth. In this study, we aimed to evaluate this effect of isotretinoin on the salivary gland function in patients with acne vulgaris using technetium-99m (Tc-99m) pertechnetate imaging of the salivary glands. Materials and methods: The study population consisted of 28 patients with acne vulgaris (6 males and 22 females, mean age 20.2 ± 2.3 years), who were treated with isotretinoin for 6 months. We performed radionuclide imaging of the salivary glands pretreatment and at months 3 and 6 of treatment. After 185 MBq (5 mCi) of Tc-99m pertechnetate was intravenously administered, imaging of the salivary glands was performed over a 25-min period. We measured the following glandular function parameters for the parotid and submandibular salivary glands via time-activity curves: uptake ratio, maximum accumulation, and ejection fraction. Results: Statistically significant differences were observed in the values obtained at months 3 and 6 of treatment, compared with the pretreatment values. Conclusion: This study demonstrated that radionuclide imaging of the salivary glands can clearly show the glandular functions that are affected by drugs such as isotretinoin.

Anahtar Kelimeler:

Radionuclide imaging of salivary glands, technetium-99m pertechnetate, isotretinoin, acne vulgaris

Evaluation of the effect of isotretinoin on salivary gland function by Tc-99m pertechnetate imaging in acne vulgaris patients

Keywords:

Radionuclide imaging of salivary glands, technetium-99m pertechnetate, isotretinoin, acne vulgaris,

PDF

___

Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol 2000; 27 (Suppl. 61): 6–10.
Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003; 9: 165–176.
Hofer E, Jensen SB, Pedersen AML, Bardow A, Nauntofte B. Oral microflora in patients with salivary gland hypofunction. Oral Biosci Med 2004; 2: 77–92.
Pochi PE. Introduction to sebaceous glands disorders. In: Demis DJ, editor. Clinical Dermatology. Philadelphia, PA, USA: JB Lippincott Company; 1991. pp. 1–25.
Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292: 726–735.
Booker J, Howarth D, Taylor L, Vountnis D, Sutherland D. Appropriate utilization of semi-quantitative analysis in salivary scintigraphy. Nucl Med Commun 2004; 25: 1203–1210.
Anjos DA, Etchebehere EC, Santos AO, Lima MCL, Ramos CD, Paula RB, Camargo EE. Normal values of 99mTc-P uptake and excretion fraction by major salivary glands. Nucl Med Commun 2006; 27: 395–403.
Klutmann S, Bohuslavizki KH, Kröger S, Bleckmann C, Brenner W, Mester J, Clausen M. Quantitative salivary gland scintigraphy. J Nucl Med Technol 1999; 27: 20–26.
Layton A. The use of isotretinoin in acne. Dermato- Endocrinology 20091; 3: 162–169.
Seven B, Yoruk O, Varoğlu E, Ucuncu H, Sahin A, Ayan K, Sutbeyazı Y. Evaluation by 99mTc-pertechnetate scintigraphy of the effect of levocetirizine on salivary glands function, in allergic rhinitis patients. Hell J Nucl Med 2009; 2: 119–122.
Raza H, Khan AU, Hameed A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun 2006; 27: 495–499.
Goulden V. Guidelines for the management of acne vulgaris in adolescents. Pediatr Drugs 2003; 5: 301–313.
Brito MF, Sant’Anna IP, Galindo JC, Rosendo LH, Santos JB. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin. An Bras Dermatol 2010; 85: 331–337.
Reynolds NJ, Gough M, Clamp JR, Burton JL. Effect of oral isotretinoin therapy on saliva volume and composition. Br J Dermatol 1991; 125: 189–190.
Lupi-Pegurier L, Muller-Bolla M, Fontas E, Ortonne JP. Reduced salivary flow ınduced by systemic ısotretinoin may lead to dental decay. A prospective clinical study. Dermatology 2007; 214: 221–226.
Oikarinen K, Salo T, Kylmaniemi M, Palatsi R, Karhunen T, Oikarinen A. Systemic oral isotretinoin therapy and flow rate, pH, and matrix metalloproteinase-9 activity of stimulated saliva. Acta Odontol Scand 1995; 53: 369–371.
Yoruk O, Seven B, Varoglu E, Ucuncu H, Sahin A, Ayan AK, Sutbeyazı Y, Tozoglu S. Evaluation of salivary gland function in allergic rhinitis patients by [99mTc] pertechnetate salivary gland scintigraphy. Cent Eur J Med 2009; 2: 246–250.
Kaya M, Cermik TF, Ustün F, Sen S, Berkarda S. Salivary function in patients with chronic renal failure undergoing hemodialysis. Ann Nucl Med 2002; 16: 117–120.
Mishkin FS. Radionuclide salivary gland imaging. Semin Nucl Med 1981; 11: 258–265.
Kohn WG, Ship JA, Atkinson JC, Patton LL, Fox PC. Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med 1992; 21: 70– 74.
Fırat F, Çermik FT, Sarıkaya A, Berkarda S. Effects of gender and age on the quantitative parameters of Tc99m pertechnetate salivary gland scintigraphy in normal subjects. Nucl Med Commun 2006; 27: 447–453.
Adams BK, Al Attia HM, Parkar S. Salivary gland scintigraphy in Sjögren’s syndrome: are quantitative indices the answer? Nuc Med Com 2003; 24: 1011–1016.
Hermann GA, Vivino FB, Shnier D, Krumm RP, Mayrin V, Shore JB. Variability of quantitative scintigraphic salivary indices in normal subjects. J Nucl Med 1998; 7: 1260–1263.
Keleş M, Seven B, Varoğlu E, Uyanık A, Cayır K, Ayayn AK, Emre H, Cetinkaya R. Salivary gland function in continuous ambulatory peritoneal dialysis patients by 99m Tc-pertechnetate scintigraphy. Hell J Nucl Med 2010; 13: 26–29.
De Rossi G, Focacci C. A computer-assisted method for semi- quantitative assessment of salivary gland diseases. Eur J Nucl Med 1980; 5: 499–503.